EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies

Nuria Alcubierre iD, Minerva Granado-Casas iD, Patricia Bogdanov iD, Cristina Hernández iD, Hugo Ramos iD, Esmeralda Castelblanco iD, Jordi Real, Esther Rubinat-Arnaldo iD, Alicia Traveset, Marta Hernández iD, Carmen Jurjo, Jesús Vioque iD und 3 weitere

Nutrients · 2023

DOI: 10.3390/nu15051169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Nuria Alcubierre und 14 weiteren Autor:innen. Beteiligte Einrichtung: Avantmedic Center, 25008 Lleida, Spain. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Diabetic Retinopathy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Educación Cultura y Deporte, Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of diabetic retinopathy (DR) in subjects with type 2 diabetes (T2D). Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. In the cross-sectional study, a total of 144 subjects with DR and 147 individuals without DR were assessed. DR was assessed by an experienced ophthalmologist. A validated food frequency questionnaire (FFQ) was administered. In the experimental model, a total of 20 mice were included. One drop (5 μL) of caffeine (5 mg/mL) (n = 10) or vehicle (5 μL PBS, pH 7.4) (n = 10) was randomly administered directly onto the superior corneal surface twice daily for two weeks in each eye. Glial activation and retinal vascular permeability were assessed using standard methods. In the cross-sectional study in humans, the adjusted-multivariable model showed that a moderate and high (Q2 and Q4) caffeine intake had a protective effect of DR (odds ratio (95% confidence interval) = 0.35 (0.16–0.78); p = 0.011 and 0.35 (0.16–0.77); p = 0.010, respectively). In the experimental model, the administration of caffeine did not improve either reactive gliosis or retinal vascular permeability. Our results suggest a dose-dependent protective effect of caffeine in the development of DR, while the potential benefits of antioxidants in coffee and tea should also be considered. Further research is needed to establish the benefits and mechanisms of caffeinated beverages in the development of DR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Diabetic RetinopathyHumansAnimalsMiceCaffeineTeaCross-Sectional StudiesCoffeeRisk Factors

Stichwörter der Autor:innen

caffeine intakecoffee consumptiondiabetic retinopathyretinal ganglion cell layertea consumptiontype 2 diabetes

Substanzen

CaffeineTeaCoffee

Autor:innen und Institutionen

  • Avantmedic Center, 25008 Lleida, Spain.
  • Department of Nursing and Physiotherapy, Health Sciences Faculty, University of Lleida, 25198 Lleida, Spain.
  • Institute of Biomedical Research in Lleida (IRBLleida), 25198 Lleida, Spain.
  • Center for Biomedical Research on Diabetes and Associated Metabolic Diseases (CIBERDEM), Instituto de Salud Carlos III, 08907 Barcelona, Spain.
  • DAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), 08041 Barcelona, Spain.
  • Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR) and Autonomous University of Barcelona (UAB), 08035 Barcelona, Spain.

ORCID-Profile: Nuria Alcubierre, Minerva Granado-Casas, Patricia Bogdanov, Cristina Hernández, Hugo Ramos, Esmeralda Castelblanco, Esther Rubinat-Arnaldo, Marta Hernández, Jesús Vioque, Eva Maria Navarrete-Muñoz, Rafael Simó, Didac Mauricio

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Educación Cultura y Deporte
  • Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas
  • Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
  • ISCIII
  • Ministerio de Educación, Cultura y Deporte

Zitieren

APA

Alcubierre, N., Granado-Casas, M., Bogdanov, P., Hernández, C., Ramos, H., Castelblanco, E., Real, J., Rubinat-Arnaldo, E., Traveset, A., Hernández, M., Jurjo, C., Vioque, J., Navarrete-Muñoz, E. M., Simó, R., & Mauricio, D. (2023). Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. https://doi.org/10.3390/nu15051169

Vancouver

Alcubierre N, Granado-Casas M, Bogdanov P, Hernández C, Ramos H, Castelblanco E, et al. Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies. Nutrients. 2023. doi:10.3390/nu15051169

BibTeX
@article{Alcubierre2023,
  author = {Alcubierre, Nuria and Granado-Casas, Minerva and Bogdanov, Patricia and Hernández, Cristina and Ramos, Hugo and Castelblanco, Esmeralda and Real, Jordi and Rubinat-Arnaldo, Esther and Traveset, Alicia and Hernández, Marta and Jurjo, Carmen and Vioque, Jesús and Navarrete-Muñoz, Eva Maria and Simó, Rafael and Mauricio, Didac},
  title = {Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies},
  journal = {Nutrients},
  year = {2023},
  doi = {10.3390/nu15051169}
}
Kostenlos starten →